Weekly Rundown: Key Catalysts for Small-Cap Stocks (October 27–31)

From recent disclosures to corporate shifts, we’ve highlighted the top small-cap catalysts to watch. Here’s your weekly preview (October 27-31).

--

Companies Participating in the ThinkEquity Conference 2025

Mandarin Oriental, New York | October 30, 2025

Participating Companies:

• FUFU • AREC • VIVK • PRPH • LTRN • BMR • VANI • CCLD • CTXR • CTOR • ROLR • FBLG • RDZN • TYGO

Companies with Material Events – Week of October 25–31, 2025:

• RCT CEO Justin Floyd will participate in the Future Investment Initiative (FII9) in Riyadh, Saudi Arabia, from October 27–30, 2025.

• INV The company is a Silver Sponsor at NVIDIA GTC Washington, D.C., taking place October 27–29 at the Walter E. Washington Convention Center.

• CODX Executive leadership will attend and host a booth at the Global Health Exhibition 2025 in Riyadh, Saudi Arabia, from October 27–30.

• FHTX Key updates for the Selective ARID1B degrader program will be presented at the 8th Annual TPD and Induced Proximity Summit in Boston (October 27–30), followed by a virtual investor event covering additional degrader programs.

• HOVR The company will attend both the Air Medical Transport Conference in Omaha (October 27–29) and the Canadian Aerospace Summit in Ottawa (October 28–29). Management will be available for 1x1 meetings.

• CXAI Will showcase its AI workplace solutions at the CoreNet Global Summit in Anaheim (October 27–29), and host an exclusive networking event on October 28 for corporate real estate executives.

• NMRA A virtual R&D Day will be hosted on Monday, October 27 at 8:00 a.m. ET, highlighting a robust pipeline for CNS disorder treatments.

• AMIX Will be featured in two podium presentations at the TCT 2025 Conference in San Francisco, running October 25–28.

• FUFU Announced sponsorship of Blockchain Life 2025 in Dubai, taking place October 28–29.

• FFAI Hosting a launch event for the FX Super One MPV at the Armani Hotel Dubai on October 28. Livestream details have been released.

• CERS Will conduct a workshop on INTERCEPT Fibrinogen Complex during the AABB Annual Meeting in San Diego (October 25–28), focused on transfusion medicine and biotherapies.

• PHIO CEO Robert Bitterman will present an update on the company’s siRNA technology and ongoing PH-762 trial for skin cancer on October 28 at 12:00 PM EST via Renmark’s Virtual Non-Deal Roadshow.

• IPHA Will host an analyst and investor event on October 28 from 8:00–10:00 a.m. ET (in-person and virtual), focusing on lacutamab and data from the Phase 2 TELLOMAK study.

• BLNE Scheduled to present at the Centurion One Capital Summit in the Bahamas on October 28–29. • USBC Will participate in the Money20/20 USA conference at the Venetian Resort in Las Vegas, from October 26–29.

• SLS Hosting a virtual R&D Day on Wednesday, October 29 at 10:00 AM ET, focusing on unmet needs and innovation in acute myeloid leukemia (AML).

• TCRX Two abstracts were accepted for ACR Convergence 2025 (October 24–29 in Chicago), including one oral presentation on October 27.

• AUTL Presenting a poster at ACR Convergence 2025 in Chicago on October 28, featuring updated CARLYSLE study data for severe refractory systemic lupus erythematosus (srSLE).

• NLSP The merger with Kadimastem is expected to close on October 30, 2025, with Kadimastem’s shares delisted from the TASE the next day, October 31. NLSP shares will be delivered to Kadimastem shareholders on or after November 3. Post-merger, Kadimastem shareholders will own 84.4% of the combined company. NLSP also received Nasdaq approval to list its shares under the new name NewcelX Ltd., with trading expected to begin under the ticker “NCEL” on October 31, pending final closing conditions.

• RELI Declared a $0.03 per share special cash dividend, payable December 2, 2025, to shareholders of record as of October 30.

• ZENA ZenaDrone will meet with U.S. lawmakers and showcase at the AUVSI Defense 2025 Forum in Washington, D.C., October 28–29.

• AMZE Announced a partnership with Breakaway Music Festival to power merchandise operations and launch the Breakaway Creator Lab design competition (Sept 30–Nov 3).

• GTBP CEO Michael Breen will present at the Centurion One Capital 3rd Annual Summit in Nassau, Bahamas, from October 28–29.

• COCH CEO Brent Lucas will present live at the Virtual Technology Investor Conference on October 28, hosted by VirtualInvestorConferences.com.

• PAPL Cooper Emmons, Pineapple advisory board member, will attend Money20/20 at the Venetian Resort in Las Vegas, October 26–29.

• BOSC CEO Eyal Cohen will present at the Atrium Index Virtual Investor Conference on October 28, with a fireside chat at 11:05 AM ET.

• INO Presenting at the International Society for Vaccines Congress in Stellenbosch, South Africa on October 30, and the World Orphan Drug Congress in Amsterdam on October 29, highlighting immunotherapy and rare disease treatments.

• NRGV Hosting a virtual Investor & Analyst Day on Wednesday, October 29 at 1:00 PM ET.

• TIXT TELUS International will hold a special shareholder meeting on October 27, 2025, to vote on its proposed arrangement agreement by TELUS Corporation, a deal valued at $539 million or $4.50 per share.

• OFAL Announced the upcoming beta launch of PlanAid, an AI tool for checking architectural designs against local building codes, expected by the end of October.

• ORGO Plans to request a pre-BLA meeting with the FDA by the end of October to discuss ReNu for knee OA, following positive Phase 3 trial results.

• LIQT Will open a new Service Center in Cresson, Texas (near Fort Worth) on November 1, 2025, in partnership with Halldor Systems.

• ESGL Extended its merger agreement with De Tomaso Automobili. The updated long-stop date is October 31, 2025.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.